MANAGEMENT OF THE HEPATOCELLULAR CARCINOMA

##plugins.themes.academic_pro.article.sidebar##

Published Dec 4, 2009
Download
pdf
Vol. 87 No. 11 (2009): Issue Nov 2009

##plugins.themes.academic_pro.article.main##

R Hefaiedh
H Elloumi
A Ouakaa
H Elloumi
A Kochlef
D Gargouri
A.Kilani M.Romani
J Kharrat
A Ghorbel
R Hefaiedh
H Elloumi
A Ouakaa
H Elloumi
A Kochlef
D Gargouri
A.Kilani M.Romani
J Kharrat
A Kilani
M Romani
J Kharrat
A Ghorbel

Abstract

Introduction: The hepatocellular carcinoma, is detected sooner due to the progress of the hepatic ultrasound scan allowing an accessibility to curative treatment. This cancer treatment still remains difficult in Tunisia.
Aim: To show the difficulties in the management of the hepatocellular carcinoma in Tunisia Patients and methods: Patients hospitalized in the gastroenterology
department of Habib Thameur Hospital, from 2002 until 2007, for a cirrhosis follow-up or for a hepatocellular carcinoma treatment were studied retrospectively. The data was summarized by descriptive statistics and analysed with SPSS version 10.
Results: Fifty-seven patients were registered in this study. There were 40 males with an average age of 66 years. The cirrhosis was post-viral C in 28 cases. The discovery of the carcinoma was systematic in 16 cases. Treatment was prescribed in only fifteen patients, in the other patients, treatment was not made because of the multifocal character of the hepatocellular carcinoma. Complications were cirrhosis decompensation (n=3), fever (n=3), portal thrombosis (n=1) and pleurisy (n=1). Conclusion: Regardless of the improvement of diagnostic and therapeutic means, 17.5% of our patients having a hepatocellular carcinoma were subjected to a
curative treatment. An additional effort must be unfolded.

Keywords:

Hepatocellular carcinoma, Surgery, Liver transplantation, Radiofrequency ablation, Percutaneous ethanol injection, Chemoembolization

##plugins.themes.academic_pro.article.details##

References

  1. Sangiovanni A, Prati GM, Fasani P et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303-10.
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
  3. Morimoto M, Numata K, Sugimori K et al. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterology 2007; 13: 1003-9.
  4. El-Serag H, Marrero J, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-63
  5. Taniguchi M, Kim SR, Imoto S et al. Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1997- 2002.
  6. Duffy JP, Hiatt JR, Busuttil RW. Surgical resection of hepatocellular carcinoma. Cancer J 2008; 14; 100-10.
  7. Raoul JL. Natural history of hepatocellular carcinoma and current treatment options. Semin Nucl Med 2008; 38: S13-8.
  8. Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-40.
  9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
  10. Heimbach JK. Liver transplantation for hepatocellular carcinoma. Cancer J 2008; 14: 95-9.
  11. Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present and future). J Gastroenterol 2008; 43: 18-26.
  12. Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Am J Roentgenol 2008; 190: W187-95.
  13. Kurokohchi K, Watanabe S, Yoneyama H et al. A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma. World J Gastroenterol 2008; 14: 2037-43.
  14. Georgiades CS, Hong K, Geschwind JF. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 2008; 14: 117-22.
  15. Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: From palliation to cure. Cancer 2006; 106: 1653-63.
  16. Dawson LA, Ten Haken RK. Partial volume tolerance to liver radiation. Semin Radiat Oncol 2005; 15: 279-83.
  17. Rougier P, Mitry E, Barbare JC, Taieb J. Hepatocellular carcinoma (HCC): an update. Semin oncol 2007; 34: S12-20.
  18. Merle P, Trepo C. Treatment of hepatocellular carcinoma in cirrhotic patients. Minerva Gastroenterol Dietol 2001; 47: 17-26